玻璃体内注射地塞米松植入物治疗自身免疫性视网膜病变。
Intravitreal Dexamethasone Implant in Autoimmune Retinopathy.
作者信息
Bordin Fernando Longhi, Mengue Carolina da Silva, Vilela Manuel Augusto Pereira
机构信息
Institute Ivo Corrêa-Meyer, Porto Alegre, Brazil.
Federal University of Health Sciences of Porto Alegre, Brazil.
出版信息
Case Rep Ophthalmol Med. 2023 Mar 31;2023:5670538. doi: 10.1155/2023/5670538. eCollection 2023.
PURPOSE
To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR).
METHODS
Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography.
RESULTS
The patients showed an interruption of the functional losses and remained stable with semestral injections.
CONCLUSION
AIR is a complex condition with no standard treatment. The use of dexamethasone could be a valid option.
目的
描述玻璃体内注射地塞米松植入物治疗自身免疫性视网膜病变（AIR）的结果。
方法
两名患有AIR的患者接受了玻璃体内地塞米松植入，并通过眼部相干断层扫描、视野检查和视网膜电图进行随访。
结果
患者的功能丧失中断，每半年注射一次后病情保持稳定。
结论
AIR是一种复杂的病症，尚无标准治疗方法。使用地塞米松可能是一种有效的选择。
Zotero 插件